September 04, 2019
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
AmEx recalls all lots of bevacizumab
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
All lots of bevacizumab 1.25 mg/0.05 mL 31-gauge injectable and bevacizumab 2.5 mg/0.1 mL Normject TB injectable from Pacifico National, doing business as AmEx Pharmacy, have been voluntarily recalled by the company, according to a press release.
The recall comes after an FDA inspection found a risk for non-sterility, which could lead to infection.
Physicians who have these products, used for the treatment of wet age-related macular degeneration and diabetic retinopathy, are asked to stop using them, remove them from inventory and return them to AmEx Pharmacy. The pharmacy can be reached at 800-644-9431 or amargio@amexpharmacy.com, while adverse reactions can be reported to the FDA’s Med Watch Adverse Event Reporting program.